(PharmaNewsWire.Com, October 25, 2019 ) OG Analysis, a global market research firm, has announced the release of their “Global Antifungal Drugs Market, Size, Share, Outlook and Growth Opportunities to 2025: By Drug Type (Echinocandins, Polyenes, Allylamines, Azoles and Other Drug Types), By Dosage Form (Powder, Tablets, Ointments and Other Dosage Forms), By Therapeutic Indication (Aspergillosis, Candidiasis, Dermatophytosis and Other Indications) and By Region” Report proposes complete outlook of the market including comprehensive market analysis, Market Share, Market Size, Market Drivers, Challenges and Opportunities.
Antifungal drugs market size projects strong growth with a rising CAGR of 4.20%. Azole group is dominant market segment in global antifungal drugs market. North America is holding the major anti-fungal drug market share. Key players are focusing on development of new products.
Growing prevalence of fungal infections such as aspergillosis, candidiasis and others is a key factor urging the need for variety antifungal drugs, which in turn boosting the market growth. Polyenes, Allylamines, Azoles and others are different antifungal drugs available in the market.
Azoles are occupying dominant position in the global market with leading therapeutic agents such as Vfend, Noxafil, Diflucan, and Cresemba. These agents maintain fungistatic activities by inhibiting fungal enzymes. Azoles are used in the treatment of systemic candidiasis, candidemia, blastomycosis, and ocular fungal infections, as they deliver broad-spectrum activity.
Rise in prevalence has surged clinical urgency to increase the usage of these drugs and has boosted development of innovative drugs. In July 2018, Sato Pharmaceutical Co., Ltd. and Eisai Co., Ltd. released NAILIN oral antifungal tablets to fulfill the needs of onychomycosis patients.
Use of combination therapies for treating wide variety of fungal infections is the current trend witnessed in the antifungal drugs market. It has been observed that a combination of topical and systemic treatment enhances the cure rate as compared to the single therapy. For instance, a combination of oral terbinafine and amorolfine nail lacquer is the widely used combination therapy.
The 2019 series of global Antifungal Drugs market size, share, outlook, trends and growth prospects is a comprehensive analysis on global Antifungal Drugs market conditions. Major trends shaping the near and long term future of the industry, opportunities, drivers and restraints of Antifungal Drugs market, detailed porter’s five forces analysis and competitive insights are included in the research report.
The report presents the detailed annual outlook of each drug type of the Antifungal Drugs market to 2025. The report studied 5 drug types including echinocandins, polyenes, allylamines, azoles and other drug types. Azole is estimated to be dominant drug type in the global Antifungal Drugs market.
The report presents in-depth insights into each of the leading Antifungal Drugs dosage forms along with annual forecasts to 2025. Various dosage forms that are studied in the report include powder, tablets, ointments and other dosage forms.
The report provides detailed Antifungal Drugs market forecasts by various therapeutic indication including aspergillosis, candidiasis, dermatophytosis and other indications. Among these different therapeutic indications, the dermatophytosis is anticipated to occupy dominant position.
The current Antifungal Drugs market size in terms of revenue across 5 regions including North America, Europe, Asia Pacific, South & Central America and Middle East & Africa are studied in the report. In addition, historic data from 2017 and annual forecasts to 2025 are also included in the research report. Globally, North America is the major market for Antifungal Drugs.
About OG Analysis: OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
